We are monitoring the impact of COVID-19 & Recession alarm on North America HPAPI Market Get in touch with us for detailed analysis Know More
Share on

North America High Potency API Market Research Report – Segmented By Type, Synthesis, Therapeutic Application & Country (The United States, Canada & Rest of North America) - Industry Analysis, Size, Share, Trends & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 2910
Pages: 145

North America HPAPI Market Size (2022 to 2027)

The size of the North American High Potency API Market was valued at USD 7.05 billion in 2022 and estimated to be growing at a CAGR of 8.9%, to reach USD 10.79 billion by 2027.

High Potency Active Pharmaceutical Ingredients (HPAPI) are pharmacological substances or intermediates which are active at concentrations of 150 micrograms per kilogram of body weight or below. They have high selectivity and usually bind to specific receptors or bind to enzymes which can lead to cancer, reproductive problems, and developmental disorders at low doses. Many new drugs in the market have these high potency active pharmaceutical ingredients leading to the high growth of the market.

These High Potency Active Pharmaceutical Ingredients have a wide range of applications, including cancer. After the mapping of the human genome, cancer drugs could be made not only for different patients but also for different cancers. The production of these drugs is difficult since they are active at very low concentrations and can cause health problems to workers during production and monitoring must be done against contamination of HPAPI production with contaminants. Hence it requires specialized equipment for managing air quality and handling HPAPI’s.

The North America High Potency API (HPAPI) Market has driving factors such as their low price, rising number of pharmaceutical manufacturers and patients, increasing government initiatives to expand the usage of generic medicines to cut down healthcare costs and growing healthcare prices. Some of the constraints faced by this market are the high price of equipment, lack of skilled workers and stringent regulatory requirements.

This research report on the North America HPAPI Market has been segmented and sub-segmented into the following categories:

By Type: 

  • Innovative HPAPI's
  • Generic HPAPI's

By Synthesis: 

  • Biotech HPAPI's
  • Synthetic HPAPI's

By Therapeutic Application: 

  • Oncology
  • Glaucoma
  • Hormonal Balance

By Country: 

  • The United States
  • Canada
  • Rest of North America

Regionally, North America has the largest market in this region is expected to be the fastest-growing. Factors such as the rising incidence of cancer, increasing demand for cancer research and rising funding for cancer-treating HPAPI’s are expected to propel the growth of this market.

Major Companies leading the North America High Potency API Market profiled in this report are Pfizer, Inc. (U.S.), Novartis International AG (Switzerland), Sanofi (France), F. Hoffmann-La Roche Ltd. (Switzerland), Eli Lilly and Company (U.S.), Bristol-Myers Squibb (U.S.), Boehringer Ingelheim (Germany), Teva Pharmaceutical Industries Ltd. (Israel), Merck & Co., Inc. (U.S.), AbbVie Inc. (U.S.), and Mylan Inc. (U.S.).

1.Introduction              

               1.1 Market Definition 

               1.2 Study Deliverables

               1.3 Base Currency, Base Year and Forecast Periods        

               1.4 General Study Assumptions               

2. Research Methodology                       

               2.1 Introduction            

               2.2 Research Phases   

                              2.2.1 Secondary Research         

                              2.2.2 Primary Research                         

                              2.2.3 Econometric Modelling   

                              2.2.4 Expert Validation

               2.3 Analysis Design      

               2.4 Study Timeline       

3. Overview                  

               3.1 Executive Summary              

               3.2 Key Inferences       

               3.3 Epidemology          

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                     

               4.1 Market Drivers      

               4.2 Market Restraints 

               4.3 Key Challenges      

               4.4 Current Opportunities in the Market              

5. Market Segmentation           

               5.1 Type          

                              5.1.1 Innovative HPAPI's                       

                              5.1.2 Generic HPAPI's  

                              5.1.3  Y-o-Y Growth Analysis, By Type   

                              5.1.4  Market Attractiveness Analysis, By Type   

                              5.1.5  Market Share Analysis, By Type   

               5.2 Synthesis  

                              5.2.1 Biotech HPAPI's  

                                             5.2.1.1 Biotech High- otency Active Pharmaceutical Ingredients Market, By Type        

        5.2.1.1.1 Innovative Biotech HPAPIs  

        5.2.1.1.2 Biosimilars

                              5.2.2 Synthetic HPAPI's                         

                                             5.2.2.1 Synthetic High Potency Active Pharmaceutical Ingredients Market, By Type       

        5.2.2.1.1 Innovative Synthetic HPAPIs                                                   

        5.2.2.1.2 Generic Synthetic HPAPIs    

                              5.2.3 Y-o-Y Growth Analysis, By Synthesis           

                              5.2.4 Market Attractiveness Analysis, By Synthesis           

                              5.2.5 Market Share Analysis, By Synthesis           

               5.3 Therapeutic Application     

                              5.3.1 Oncology                        

                              5.3.2 Glaucoma                       

                              5.3.3 Hormonal Balance                       

                              5.3.4 Other therapeutic applications     

                              5.3.5 Y-o-Y Growth Analysis, By Therapeutic Application

                              5.3.6  Market Attractiveness Analysis, By Therapeutic Application                        

                              5.3.7  Market Share Analysis, By Therapeutic Application                         

               5.4 Manufacturer        

                              5.4.1 Captive Manufacturers    

                              5.4.2 Merchant Manufacturers

                                             5.4.2.1 Merchant HPAPI Manufacturers Market, By Type          

        5.4.2.1.1 Innovative Merchant HPAPI Manufacturers  

        5.4.2.1.2 Generic Merchant HPAPI Manufacturers       

                                             5.4.2.2 Merchant HPAPI Manufacturers Market, By Type of Synthesis                      

        5.4.2.2.1 Synthetic HPAPIs    

        5.4.2.2.2 Biotech HPAPIs       

                              5.4.3 Y-o-Y Growth Analysis, By Manufacturer   

                              5.4.4  Market Attractiveness Analysis, By Manufacturer 

                              5.4.5  Market Share Analysis, By Manufacturer  

6. Geographical Analysis           

               6.1 Introduction            

                              6.1.1 Regional Trends  

                              6.1.2 Impact Analysis   

                              6.1.3 Y-o-Y Growth Analysis      

                                             6.1.3.1 By Type         

                                             6.1.3.2 By Synthesis                

                                             6.1.3.3 By Therapeutic Application                    

                                             6.1.3.4 By Manufacturer        

                              6.1.4  Market Attractiveness Analysis    

                                             6.1.4.1 By Type         

                                             6.1.4.2 By Synthesis                

                                             6.1.4.3 By Therapeutic Application                    

                                             6.1.4.4  By Manufacturer                      

                              6.1.5  Market Share Analysis     

                                             6.1.5.1 By Type         

                                             6.1.5.2 By Synthesis                

                                             6.1.5.3 By Therapeutic Application                    

                                             6.1.5.4 By Manufacturer        

               6.2 United States         

               6.3 Canada     

7.Strategic Analysis                    

               7.1 PESTLE analysis     

                              7.1.1 Political 

                              7.1.2 Economic                        

                              7.1.3 Social     

                              7.1.4 Technological     

                              7.1.5 Legal      

                              7.1.6 Environmental    

               7.2 Porter’s Five analysis           

                              7.2.1 Bargaining Power of Suppliers  

  1. North America High Potency Active Pharmaceutical Ingredients Market, By Type, From 2022 - 2027 (USD Million)
  2. North America Innovative HPAPI's  Market, By Region, From 2022 - 2027 (USD Million)
  3. North America Generic HPAPI's Market, By Region, From 2022 - 2027 (USD Million)
  4. North America High Potency Active Pharmaceutical Ingredients Market, By Synthesis, From 2022 - 2027 (USD Million)
  5. North America Biotech HPAPI's Market, By Region, From 2022 - 2027 (USD Million)
  6. North America Synthetic HPAPI's Market, By Region, From 2022 - 2027 (USD Million)
  7. North America High Potency Active Pharmaceutical Ingredients Market, By Therapeutic Application, From 2022 - 2027 (USD Million)
  8. North America Oncology Market, By Region, From 2022 - 2027 (USD Million)
  9. North America Glaucoma Market, By Region, From 2022 - 2027 (USD Million)
  10. North America Hormonal Balance Market, By Region, From 2022 - 2027 (USD Million)
  11. North America other therapeutic applications Market, By Region, From 2022 - 2027 (USD Million)
  12. United States High Potency Active Pharmaceutical Ingredients Market, By Type, From 2022 - 2027 (USD Million)
  13. United States High Potency Active Pharmaceutical Ingredients Market, By Synthesis, From 2022 - 2027 (USD Million)
  14. United States High Potency Active Pharmaceutical Ingredients Market, By Therapeutic Application, From 2022 - 2027 (USD Million)
  15. Canada High Potency Active Pharmaceutical Ingredients Market, By Type, From 2022 - 2027 (USD Million)
  16. Canada High Potency Active Pharmaceutical Ingredients Market, By Synthesis, From 2022 - 2027 (USD Million)
  17. Canada High Potency Active Pharmaceutical Ingredients Market, By Therapeutic Application, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample